Quantum Earnings Calls
| Release date | Sep 09, 2026 |
| EPS estimate | -$0.260 |
| EPS actual | - |
| Revenue estimate | 70M |
| Revenue actual | - |
| Expected change | +/- 13.76% |
| Release date | Jun 15, 2026 |
| EPS estimate | -$0.310 |
| EPS actual | -$0.210 |
| EPS Surprise | 32.26% |
| Revenue estimate | 72.75M |
| Revenue actual | 78M |
| Revenue Surprise | 7.22% |
| Release date | Feb 17, 2026 |
| EPS estimate | -$0.420 |
| EPS actual | -$0.360 |
| EPS Surprise | 14.29% |
| Revenue estimate | 72.7M |
| Revenue actual | 74.586M |
| Revenue Surprise | 2.59% |
| Release date | Nov 13, 2025 |
| EPS estimate | -$0.250 |
| EPS actual | -$0.540 |
| EPS Surprise | -116.00% |
| Revenue estimate | 65.878M |
| Revenue actual | 62.715M |
| Revenue Surprise | -4.80% |
Last 4 Quarters for Quantum
Below you can see how QMCO performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Nov 13, 2025 |
| Price on release | $7.03 |
| EPS estimate | -$0.250 |
| EPS actual | -$0.540 |
| EPS surprise | -116.00% |
| Date | Price |
|---|---|
| Nov 07, 2025 | $8.18 |
| Nov 10, 2025 | $8.19 |
| Nov 11, 2025 | $7.88 |
| Nov 12, 2025 | $7.70 |
| Nov 13, 2025 | $7.03 |
| Nov 14, 2025 | $7.87 |
| Nov 17, 2025 | $7.39 |
| Nov 18, 2025 | $7.71 |
| Nov 19, 2025 | $7.64 |
| 4 days before | -14.06% |
| 4 days after | 8.68% |
| On release day | 11.95% |
| Change in period | -6.60% |
| Release date | Feb 17, 2026 |
| Price on release | $5.61 |
| EPS estimate | -$0.420 |
| EPS actual | -$0.360 |
| EPS surprise | 14.29% |
| Date | Price |
|---|---|
| Feb 10, 2026 | $6.16 |
| Feb 11, 2026 | $6.32 |
| Feb 12, 2026 | $5.79 |
| Feb 13, 2026 | $5.78 |
| Feb 17, 2026 | $5.61 |
| Feb 18, 2026 | $5.47 |
| Feb 19, 2026 | $5.56 |
| Feb 20, 2026 | $5.36 |
| Feb 23, 2026 | $5.25 |
| 4 days before | -8.93% |
| 4 days after | -6.42% |
| On release day | -2.50% |
| Change in period | -14.77% |
| Release date | Jun 15, 2026 |
| Price on release | $13.97 |
| EPS estimate | -$0.310 |
| EPS actual | -$0.210 |
| EPS surprise | 32.26% |
| Date | Price |
|---|---|
| Jun 09, 2026 | $13.05 |
| Jun 10, 2026 | $12.59 |
| Jun 11, 2026 | $13.06 |
| Jun 12, 2026 | $13.74 |
| Jun 15, 2026 | $13.97 |
| Jun 16, 2026 | $14.41 |
| Jun 17, 2026 | $14.95 |
| Jun 18, 2026 | $15.60 |
| Jun 22, 2026 | $14.04 |
| 4 days before | 7.05% |
| 4 days after | 0.501% |
| On release day | 3.15% |
| Change in period | 7.59% |
| Release date | Sep 09, 2026 |
| Price on release | - |
| EPS estimate | -$0.260 |
| EPS actual | - |
| Date | Price |
|---|---|
| Jun 29, 2026 | $11.85 |
| Jun 30, 2026 | $11.00 |
| Jul 01, 2026 | $10.93 |
| Jul 02, 2026 | $10.16 |
| Jul 06, 2026 | $10.53 |
Quantum Earnings Call Transcript Summary of Q1 2026
Quantum reported fiscal Q1 2026 revenue of $64.3M (down vs. prior year and slightly up sequentially) with GAAP gross margin 35.3% and a GAAP net loss of $17.2M. Backlog was ~$10M. The company reduced net debt to ~$66.8M and raised roughly $83M of equity through a standby purchase agreement, paid off and terminated its revolver, and is negotiating term-debt restructuring. Management executed cost-reduction and restructuring actions; non-GAAP OpEx is expected to decline to about $27M in Q2, helping adjusted EBITDA move from negative $6.5M in Q1 to roughly breakeven in Q2. Q2 revenue guidance is ~$61M +/- $2M and non-GAAP adjusted net loss per share is expected around -$0.26 (+/- $0.10) on ~13.3M shares. Operational priorities include sharpening go-to-market execution, strengthening the sales organization (new CRO Tony Craythorne and VP Americas Gregg Pugmire), board additions for supply chain and sales expertise, and a product-first focus on DXi (all‑flash dedupe appliances), ActiveScale cold storage, tape (Scalar i7 RAPTOR), and StorNext improvements. Management emphasized improved sales discipline, partner/channel focus, tighter sales-to-product feedback loops, and delivering positive cash flow/EBITDA. Key near-term risks remain revenue mix sensitivity to gross margin (hyperscaler mix), tariffs, inventory provisions (end-of-life products), and ongoing debt restructuring outcomes.
Sign In
Buy QMCO